Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating the efficacy of enalapril, eplerenone alone, and their combination on proteinuria
IRCT20250817066890N1Phase 2Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of enalapril and eplerenone in diabetic glomerulosclerosis (3 arms), sponsored by Kashan University of Medical Sciences. Primary endpoint: Change in proteinuria. Started Aug 2025; status: completed.
02
Drugs
enalaprileplerenone
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on IRCT20250817066890N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250817066890N1.